Optura.ai

ai specializes in developing AI solutions for the healthcare industry. The founder's background in technology and healthcare allows for a deep understanding of industry challenges, though specific past ventures have not been disclosed. Optura specializes in healthcare AI solutions through its flagship product, the AI Enterprise Operating System (AIEOS). This platform is designed to streamline and orchestrate AI initiatives within healthcare organizations, enabling them to transition from fragmented pilot programs to comprehensive, enterprise-scale AI programs that yield measurable results. AIEOS integrates advanced AI capabilities to address challenges faced by healthcare payers, including operational inefficiencies, cost management, and the need for demonstrable return on investment (ROI). The platform is tailored for compliance with regulatory standards such as HIPAA and CMS, ensuring secure deployment across critical workflows.Optura's revenue model is primarily built around a subscription-based structure for its AIEOS platform, which facilitates long-term partnerships with its healthcare clients. This model allows organizations to access the comprehensive suite of AI tools and services offered by Optura, with pricing typically structured around the scale and specific functionalities adopted by the client. Transactions generally occur through annual contracts, which include provisions for maintenance and support services, thereby ensuring client engagement and satisfaction. While specific pricing details are proprietary, the value proposition centers on delivering significant ROI through streamlined operations and cost savings. The company’s focus on measurable outcomes positions it as a critical partner for healthcare organizations looking to enhance their efficiency and competitiveness in the market.

1. Series A

   Mar 23, 2026

   Amount

   $21M

   Investors

   Locked

2. Seed

   May 20, 2025

   Amount

   $6.5M

   Investors

   Locked